Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
Apnimed has raised $50.0M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2026.
Apnimed's investors include Alpha Wave Global, HealthCare Royalty Partners, Tao Capital Partners, Morningside, Alpha Wave Ventures.
Apnimed is headquartered in Cambridge, United States.
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
Apnimed is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apnimed — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/apnimed. Accessed July 19, 2026.
VCBacked. (2026). Apnimed — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/apnimed
{{cite web |title=Apnimed — Funding & Investors |url=https://www.vcbacked.co/company/apnimed |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated